– USA, NY – IBM (NYSE: IBM) today announced that its board of directors yesterday elected Bill McNabb to the board.
The election to the IBM board is effective October 29, 2019, at which time the IBM board will have a total of 13 directors.
Ginni Rometty, IBM chairman, president and CEO, said: “Bill McNabb is an outstanding business executive, well known for his leadership in corporate governance. His experience in global investing and deep commitment to delivering long-term shareholder value will make him a powerful addition to the IBM board.”
About Bill McNabb
Mr. McNabb is the former CEO and chairman of The Vanguard Group, Inc. He served in various leadership roles at Vanguard before being named chief executive officer in 2008 and chairman in 2010. He retired as chief executive officer in 2017 and as Vanguard’s board chairman a year later. He is a member of the board of directors of UnitedHealth Group and of CECP: The CEO Force For Good.
Mr. McNabb is a graduate of Dartmouth College and earned an M.B.A. from the Wharton School of the University of Pennsylvania.
About IBM
IBM is a leading cloud platform and cognitive solutions company. Restlessly reinventing since 1911, we are the largest technology and consulting employer in the world, with more than 380,000 employees serving clients in 170 countries. With Watson, the AI platform for business, powered by data, we are building industry-based solutions to real-world problems. For more than seven decades, IBM Research has defined the future of information technology with more than 3,000 researchers in 12 labs located across six continents.
For more information, visit www.ibm.com.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.